[131-I MIBG therapy of malignant pheochromocytoma and paraganglioma tumors - a single center study.]

CONCLUSIONS: Radionuclide treatment with use of 131-I MIBG may be effective form of palliative treatment for patients with inoperative neoplasm spread, progressive disease or patients requiring alleviation of symptoms.
PMID: 29645065 [PubMed - as supplied by publisher]

Source: Endokrynologia Polska - April 12, 2018 Category: Endocrinology Authors: Kotecka-Blicharz A, Hasse-Lazar K, Handkiewicz-Junak D, Gawlik T, Pawlaczek A, Oczko-Wojciechowska M, Michalik B, Szpak-Ulczok S, Krajewska J, Jurecka-Lubieniecka B, Jarząb B Tags: Endokrynol Pol Source Type: research